Medical devices face tougher premarket testing under new EU laws

BMJ 2017; 357: j1870
Author: Deborah Cohen
“The European Parliament has passed new legislation to tighten regulation of medical devices that will require high risk devices, such as hip implants, to undergo more premarket testing and assessment. European device regulation has come in for criticism after a series of high profile failures—including hip replacements, breast implants, and pelvic meshes—that have resulted in harm to patients.”
Find article here.

Decriminalisation in the NT signals abortion is part of normal health care

The Conversation, 24 March 2017
Author: Suzanne Belton
“The Northern Territory parliament this week passed a bill decriminalising abortion up to 24 weeks’ gestation, removing the requirement of parental approval for abortions in teenagers and providing early medical abortions with tablets.”
Find article here.

In places where it’s legal, how many people are ending their lives using euthanasia?

The Conversation, 3 March 2017
Author: Andrew McGee
“The Victorian Parliament will consider a bill to legalise euthanasia in the second half of 2017. That follows the South Australian Parliament’s decision to knock back a voluntary euthanasia bill late last year, and the issue has also cropped up in the run-up to the March 11 Western Australian election. With the issue back in the headlines, federal Labor’s justice spokesperson, Clare O’Neil, told Q&A that in countries where the practice is legal, “very, very small” numbers of people use the laws.”
Find article here.

Victoria’s world-first change to share sperm or egg donors’ names with children

The Conversation, 1 March 2017
Author: Karin Hammarberg
“More people conceived using donor sperm or eggs in Victoria will from today have the legal right to know details about their donor, even if the donation was made anonymously or the donor didn’t give consent to being identified.”
Find article here.

Drug Makers Accused of Fixing Prices on Insulin

NYT, 30 January 2017
Author: Katie Thomas
“A lawsuit filed Monday accused three makers of insulin of conspiring to drive up the prices of their lifesaving drugs, harming patients who were being asked to pay for a growing share of their drug bills. The price of insulin has skyrocketed in recent years, with the three manufacturers — Sanofi, Novo Nordisk and Eli Lilly — raising the list prices of their products in near lock step, prompting outcry from patient groups and doctors who have pointed out that the rising prices appear to have little to do with increased production costs.”
Find article here.